Interstitial 3q deletions have been associated with a broad phenotype including dysmorphic facial features, ear and digit abnormalities, hypogonadism, intracranial malformations, cardiac and renal defects, intellectual disability, and developmental delay.^[@bibr1-2329048X16666362]^ Most reported cases have features consistent with blepharophimosis--ptosis--epicanthus inversus syndrome (OMIM: 110100). The blepharophimosis--ptosis--epicanthus inversus syndrome is a rare disorder associated with a collection of characteristic eyelid malformations---short palpebral fissures (blepharophimosis), ptosis, epicanthus inversus, and telecanthus. It is inherited in an autosomal-dominant manner with close to half of cases thought to arise from a de novo mutation.^[@bibr2-2329048X16666362]^ A strong association has been established between blepharophimosis--ptosis--epicanthus inversus syndrome and deletions in the 3q23 region causing haploinsufficiency of the *FOXL2* gene (OMIM: 605597).^[@bibr3-2329048X16666362]^

Dandy-Walker malformation (OMIM: 220200) is the most common congenital defect of the cerebellum. It is defined by hypoplasia and upward rotation of the cerebellar vermis with associated dilatation of the fourth cerebral ventricle.^[@bibr4-2329048X16666362]^ Dandy-Walker malformation has been described in association with a wide variety of genetic disorders including 3q microdeletions. It is thought to arise sporadically with no defined Mendelian inheritance.^[@bibr5-2329048X16666362]^ Recent reports have proposed a link between Dandy-Walker malformation and interstitial 3q24 deletions affecting the *ZIC1* (OMIM: 600470) and *ZIC4* (OMIM: 608948) candidate genes.^[@bibr6-2329048X16666362]^

Wisconsin syndrome is a very rare phenotype first delineated by John M. Opitz in 1976 and later reported by Cohen.^[@bibr7-2329048X16666362]^ It was originally described as a combination of craniosynostosis, intellectual disability, upslanted palpebral fissures, small ears, and recessed fourth toes with short fourth metatarsals. The genetic basis of Wisconsin syndrome has been narrowed to the 3q24q25 region after the identification of further cases with 3q microdeletions.^[@bibr4-2329048X16666362]^

In this article, the authors describe a female patient with a phenotype encompassing the features of blepharophimosis--ptosis--epicanthus inversus syndrome, Dandy-Walker malformation, and Wisconsin syndrome. Genomic analysis revealed a large de novo microdeletion at 3q22.3q24, which includes *FOXL2, ZIC1*, and *ZIC4.* This case provides further evidence for the pathogenicity of *ZIC1* and *ZIC4* in Dandy-Walker malformation. This patient is also one of few cases linking the Wisconsin syndrome phenotype to 3q microdeletions.

Case Report {#section1-2329048X16666362}
===========

The patient was the first child of healthy nonconsanguineous parents. She had an uncomplicated antenatal period and was delivered at term. In the first few months of life, she was noted to be clinically microcephalic with a head circumference below the third percentile. She also exhibited several dysmorphic features. These included several eyelid abnormalities such as short and upslanted palpebral fissures, blepharophimosis, ptosis, epicanthus inversus, and telecanthus. She was also noted to have a prominent nose, coarse features, small low-set ears, and recessed fourth toes.

The patient was sent for comparative genomic hybridization (CGH) array testing at 2 months of age. Analysis was undertaken on a peripheral blood sample using the Affymetrix CytoScan 750 K platform (Affymetrix, CA, USA). This system has an effective copy number resolution of 200 kb and a long contiguous stretches of homozygosity resolution of 5 Mb. The reference sequence used for mapping was Genome Reference Consortium Human Build 37 (hg19). Software analysis was performed with the Affymetrix Chromosome Analysis Suite. Testing demonstrated a female profile with a large 12 Mb interstitial deletion within chromosome 3 from band 3q22.3 to 3q24 (chr3:136,403,035-148,341,113). This microdeletion is depicted in [Figure 1](#fig1-2329048X16666362){ref-type="fig"} and encompasses 60 RefSeq genes. Subsequent karyotype testing of the patient's parents demonstrated no abnormalities, confirming that her microdeletion had arisen de novo.

![Graphical representation of the RefSeq genes within the patient's interstitial deletion at 3q22.3q24. Generated using the University of California Santa Cruz genome browser (<https://genome.ucsc.edu>).](10.1177_2329048X16666362-fig1){#fig1-2329048X16666362}

The magnetic resonance imaging of the patient's brain was undertaken at 4 months of age as shown in [Figure 2](#fig2-2329048X16666362){ref-type="fig"}. This revealed hypoplasia of the cerebellar vermis with associated enlargement of the fourth cerebral ventricle. The patient also had a thinned corpus callosum and general prominence of her cerebrospinal fluid spaces consistent with a reduction in overall cerebral volume. By 8 months of age, the patient had also undergone renal and cardiac ultrasounds, which were normal. Ophthalmology assessment demonstrated significant anisometropia with a spherical refractive error of +1.25 in the right eye and −2.25 in the left. The patient underwent bilateral frontalis suspension surgery at 8 months of age using Visitec slings to lift her upper eyelids. She also underwent bilateral epicanthic fold reductions at 13 months of age to improve the cosmetic appearance of her eyes.

![T1-weighted sagittal magnetic resonance imaging (MRI) of the patient's brain. Hypoplasia of the cerebellar vermis is shown with associated enlargement of the fourth cerebral ventricle.](10.1177_2329048X16666362-fig2){#fig2-2329048X16666362}

At 6 months of age, the patient showed a tendency to increased extensor tone in the lower limbs with exaggerated toe grasp reflexes. She also presented with poor core stability and postural control, although her early prelingual speech and language were quite normal at this stage. By 12 months of age, the patient had a significant reduction in her tendency for excessive leg extensor tone and toe grasp. Her postural and balance control had also markedly improved. She presented overall at the lower end of normal for her developmental milestones, with gross motor and play skills equivalent to a normal 8-month-old child. Her fine motor skills and social development were progressing normally. By 18 months of age, the patient presented with excellent development of her receptive and expressive language and good progression of her motor skills.

Discussion {#section2-2329048X16666362}
==========

The authors have reported on a patient presenting with a multifaceted phenotype including microcephaly, dysmorphic facial features, digital abnormalities, intracranial malformations, and early developmental delay. Genomic analysis revealed a large de novo interstitial deletion at 3q22.3q24 including *FOXL2*, *ZIC1*, and *ZIC4*. The elements of this patient's phenotype represent a combination of blepharophimosis--ptosis--epicanthus inversus syndrome, Dandy-Walker malformation, and Wisconsin syndrome. This case is one of few with Dandy-Walker malformation to have associated corpus callosum thinning. It also provides additional evidence for the role of *ZIC1* and *ZIC4* in this disease. This is also only the seventh reported case of a patient exhibiting the Wisconsin syndrome phenotype.

The patient's eyelid abnormalities are consistent with the well-recognized features of blepharophimosis--ptosis--epicanthus inversus syndrome. Recent literature has established a strong association between haploinsufficiency of *FOXL2* and blepharophimosis--ptosis--epicanthus inversus syndrome. The *FOXL2* is a putative forkhead transcription factor gene located at 3q23 and was first described in connection with blepharophimosis--ptosis--epicanthus inversus syndrome by Crisponi et al.^[@bibr3-2329048X16666362]^ Several studies have shown that *FOXL2* is present in the developing eyelids of both mice and humans, and it remains the only gene known to be associated with blepharophimosis--ptosis--epicanthus inversus syndrome.^[@bibr3-2329048X16666362],[@bibr8-2329048X16666362]-[@bibr11-2329048X16666362]^ Most cases of blepharophimosis--ptosis--epicanthus inversus syndrome are thought to arise from intragenic mutations of *FOXL2*, with a smaller proportion resulting from 3q23 microdeletions.^[@bibr9-2329048X16666362]^ There remains uncertainty about the correlation between the extent of *FOXL2* deletion or mutation with the severity of the blepharophimosis--ptosis--epicanthus inversus syndrome phenotype.^[@bibr12-2329048X16666362]^ Several recent reports have described patients with blepharophimosis--ptosis--epicanthus inversus syndrome with an intact *FOXL2* region but nearby interstitial deletions.^[@bibr9-2329048X16666362]-[@bibr10-2329048X16666362]^ This suggests the presence of *FOXL2* regulatory elements within 3q23. Deletion or mutation of these regulatory regions may be sufficient to cause blepharophimosis--ptosis--epicanthus inversus syndrome rather than disruption of *FOXL2* itself.

Two types of blepharophimosis--ptosis--epicanthus inversus syndrome have been established after initial description by Zlotogora et al.^[@bibr13-2329048X16666362]^ Type 1 includes the characteristic eyelid features as well as female infertility, whereas type 2 involves the eyelid abnormalities alone. Several reports have been made of patients with blepharophimosis--ptosis--epicanthus inversus syndrome and associated ovarian failure.^[@bibr14-2329048X16666362],[@bibr15-2329048X16666362]^ This has been reinforced by studies demonstrating the expression of *FOXL2* in developing ovaries and that *FOXL2* mutations can be associated with ovarian tumours.^[@bibr16-2329048X16666362],[@bibr17-2329048X16666362]^ The patient will require close follow-up during adolescence to establish whether her ovarian function will be affected.

The posterior fossa pathology this patient presented with is suggestive of a mild variant of Dandy-Walker malformation. There was also associated reduction in overall cerebral volume and thinning of the corpus callosum. The genetic basis of Dandy-Walker malformation remains relatively poorly understood, and it has been reported in association with many chromosomal abnormalities. Grinberg et al^[@bibr6-2329048X16666362]^ defined the first critical region at 3q24q25.1 after comparing 8 patients with Dandy-Walker malformation and 3q deletions. Some of these patients had milder variants of Dandy-Walker malformation similar to this patient's presentation. *ZIC1* and *ZIC4* were suggested as possible candidate genes as they encode zinc finger proteins that have been linked to cerebellar and spinal cord development.^[@bibr4-2329048X16666362]^ Mouse models have demonstrated that deletion of *ZIC1* and *ZIC4* can cause variable hypoplasia of the cerebellum and similar posterior fossa abnormalities to Dandy-Walker malformation.^[@bibr6-2329048X16666362],[@bibr18-2329048X16666362]^ There have subsequently been at least 7 additional cases reported with features of Dandy-Walker malformation and associated 3q deletions affecting *ZIC1* and *ZIC4*.^[@bibr4-2329048X16666362]-[@bibr5-2329048X16666362],[@bibr19-2329048X16666362]-[@bibr22-2329048X16666362]^ A comparison of the 15 total cases is presented in [Table 1](#table1-2329048X16666362){ref-type="table"}. There is a wide variation in the severity of Dandy-Walker malformation between these patients. Almost all were reported to have some associated developmental delay and approximately half had concurrent blepharophimosis--ptosis--epicanthus inversus syndrome. The patient provides further evidence for the pathogenicity of *ZIC1* and *ZIC4* in Dandy-Walker malformation. This is also only the third reported case of Dandy-Walker malformation to have associated corpus callosum thinning.

###### 

Overview of DWM Patients With 3q Deletions.

![](10.1177_2329048X16666362-table1)

                                  Current Patient, 2016                             Grinberg et al,^[@bibr6-2329048X16666362]^ 2004   Grinberg et al,^[@bibr6-2329048X16666362]^ 2004   Grinberg et al,^[@bibr6-2329048X16666362]^ 2004   Grinberg et al,^[@bibr6-2329048X16666362]^ 2004   Grinberg et al,^[@bibr6-2329048X16666362]^ 2004   Grinberg et al,^[@bibr6-2329048X16666362]^ 2004   Grinberg et al,^[@bibr6-2329048X16666362]^ 2004
  ------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- -------------------------------------------------
  Patient details                                                                                                                                                                                                                                                                                                                                                                               
   Identifier                     −                                                 LR00-225                                          LR03-384                                          LR01-306                                          LR01-242                                          LR02-027                                          LR03-317                                          LR01-273
   3q deletion                    3q22.3q24                                         3q22.2q25.2                                       3q22q26                                           3q23q25.31                                        3q23q25.31                                        3q23q25.1                                         3q24q25.1                                         3q22.2q25.1
  DWM features                                                                                                                                                                                                                                                                                                                                                                                  
   Severity of  imaging changes   \+                                                ++                                                +++                                               \+                                                \+                                                +++                                               ++                                                ++
  Other features                                                                                                                                                                                                                                                                                                                                                                                
   Corpus callosum  thinning      \+                                                NR                                                NR                                                NR                                                NR                                                NR                                                NR                                                NR
   Microcephaly                   \+                                                NR                                                NR                                                NR                                                NR                                                NR                                                NR                                                NR
   BPES                           \+                                                \+                                                −                                                 \+                                                −                                                 −                                                 −                                                 \+
   Developmental  delay           \+                                                \+                                                \+                                                \+                                                \+                                                \+                                                \+                                                \+
                                  Grinberg et al,^[@bibr6-2329048X16666362]^ 2004   Lim et al,^[@bibr19-2329048X16666362]^ 2011       Ramieri et al,^[@bibr20-2329048X16666362]^ 2011   Tohyama et al,^[@bibr5-2329048X16666362]^ 2011    Weber et al,^[@bibr22-2329048X16666362]^ 2011     D'Amours,^[@bibr21-2329048X16666362]^ 2012        Ferraris et al,^[@bibr4-2329048X16666362]^ 2013   Ferraris et al,^[@bibr4-2329048X16666362]^ 2013
  Patient details                                                                                                                                                                                                                                                                                                                                                                               
   Identifier                     LR01-325                                          −                                                 −                                                 −                                                 HD24                                                                                                CCM067                                            CCM095
   3q deletion                    3q25.1q25.33                                      3q22.3q25.2                                       3q22.1q25.2                                       3q23q25.1                                         3q23q25.1                                         3q25.1q25.32                                      3q22.3q25.31                                      3q23q26.1
  DWM features                                                                                                                                                                                                                                                                                                                                                                                  
   Severity of imaging  changes   ++                                                ++                                                ++                                                \+                                                ++                                                \+                                                +++                                               +++
  Other features                                                                                                                                                                                                                                                                                                                                                                                
   Corpus callosum  thinning      NR                                                NR                                                NR                                                NR                                                NR                                                NR                                                \+                                                \+
   Microcephaly                   −                                                 −                                                 \+                                                −                                                 \+                                                −                                                 NR                                                NR
   BPES                           −                                                 \+                                                \+                                                −                                                 \+                                                −                                                 \+                                                −
   Developmental  delay           \+                                                \+                                                \+                                                \+                                                \+                                                NR                                                \+                                                \+

Abbreviations: BPES, blepharophimosis--ptosis--epicanthus inversus syndrome; DWM, Dandy-Walker malformation; NR, not reported.

*Note*. + = mild, ++ = moderate, +++ = severe.

The patient's unusual dysmorphic features were reminiscent of the rare Wisconsin syndrome phenotype. Ko et al^[@bibr23-2329048X16666362]^ reported the second case of Wisconsin syndrome in 2002 and identified an associated 3q microdeletion. Willemsen et al^[@bibr24-2329048X16666362]^ subsequently described the third and fourth cases and narrowed the critical region to 3q24q25. Ferraris et al^[@bibr4-2329048X16666362]^ then recently reported the fifth and sixth cases and proposed more accurate diagnostic criteria---coarse facies, prominent nasal tip, bushy eyebrows, high arched/upsweeping eyebrows, and a full/everted lower lip. A comparison of the 6 cases is presented in [Table 2](#table2-2329048X16666362){ref-type="table"}. This patient is only the seventh reported case of the Wisconsin syndrome phenotype and contributes to the association between Wisconsin syndrome and 3q deletions. This is also only the second Wisconsin syndrome case to have associated blepharophimosis--ptosis--epicanthus inversus syndrome and the third with concurrent Dandy-Walker malformation. This patient differs from the other reported cases in that her developmental delay only manifested early in life and had improved markedly by 18 months of age. The other reported patients with Wisconsin syndrome all had persisting developmental delay and intellectual disability beyond this age.

###### 

Overview of Patients With WS Having 3q Deletions.

![](10.1177_2329048X16666362-table2)

                                        Current Patient, 2016   Cohen,^[@bibr7-2329048X16666362]^ 1986   Ko,^[@bibr23-2329048X16666362]^ 2003   Willemsen,^[@bibr24-2329048X16666362]^ 2011   Willemsen,^[@bibr24-2329048X16666362]^ 2011   Ferraris et al,^[@bibr4-2329048X16666362]^ 2013   Ferraris et al,^[@bibr4-2329048X16666362]^ 2013
  ------------------------------------- ----------------------- ---------------------------------------- -------------------------------------- --------------------------------------------- --------------------------------------------- ------------------------------------------------- -------------------------------------------------
  Patient details                                                                                                                                                                                                                                                                             
   Identifier                           −                       −                                        −                                      1                                             2                                             CCM067                                            CCM095
   3q deletion                          3q22.3q24               NR                                       3q23q25                                3q23q25.3                                     3q25.1q25.33                                  3q22.3q25.31                                      3q23q26.1
  Original WS features                                                                                                                                                                                                                                                                        
   Intellectual disability              −                       \+                                       \+                                     \+                                            \+                                            \+                                                \+
   Upslanted palpebral fissures         \+                      \+                                       \+                                     \+                                            −                                             \+                                                −
   Small ears                           \+                      \+                                       −                                      −                                             −                                             −                                                 −
   Recessed fourth toes                 \+                      \+                                       \+                                     NR                                            NR                                            \+                                                \+
  Revised WS features                                                                                                                                                                                                                                                                         
   Coarse facies                        \+                      \+                                       \+                                     \+                                            \+                                            \+                                                \+
    Prominent nasal tip                 \+                      \+                                       \+                                     \+                                            \+                                            \+                                                \+
    Bushy eyebrows                      \+                      \+                                       \+                                     \+                                            \+                                            \+                                                \+
    High arched/upsweeping   eyebrows   \+                      \+                                       \+                                     \+                                            \+                                            \+                                                \+
    Full/everted lower lip              \+                      \+                                       \+                                     \+                                            \+                                            \+                                                \+
   Other features                                                                                                                                                                                                                                                                             
    BPES                                \+                      −                                        −                                      −                                             −                                             \+                                                −
    DWM                                 \+                      NR                                       NR                                     NR                                            NR                                            \+                                                \+

Abbreviations: BPES, blepharophimosis--ptosis--epicanthus inversus syndrome; DWM, Dandy-Walker malformation; NR, not reported; WS, Wisconsin syndrome.

*Note*. + = present, − = absent.
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